More importantly, they found newly uncovered mechanisms of ATF3 action in the transcriptional regulation of hepatic lipid metabolism, thus revealing an unanticipated protective role of ATF3 in the development and progression of NAFLD and atherosclerosis (Xu et al., 2021a, b). The gene discussed is ATF3; the disease is metabolic dysfunction-associated steatotic liver disease.